LEGN
Legend Biotech CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.46B
P/E Ratio
—
EPS
$-1.38
Beta
0.30
52W High
$45.30
52W Low
$16.24
50-Day MA
$22.40
200-Day MA
$26.06
Dividend Yield
—
Profit Margin
-22.00%
Forward P/E
196.08
PEG Ratio
—
About Legend Biotech Corp
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
Fundamentals
| Revenue (TTM) | $1.14B |
| Gross Profit (TTM) | $227.80M |
| EBITDA | $-125.10M |
| Operating Margin | -16.30% |
| Return on Equity | -25.20% |
| Return on Assets | -5.24% |
| Revenue/Share (TTM) | $6.17 |
| Book Value | $5.42 |
| Price-to-Book | 5.64 |
| Price-to-Sales (TTM) | 4.79 |
| EV/Revenue | 4.403 |
| EV/EBITDA | -15.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 56.50% |
| Shares Outstanding | $185.74M |
| Float | $164.99M |
| % Insiders | 1.31% |
| % Institutions | 54.08% |
Historical Volatility
HV 10-Day
83.55%
HV 20-Day
77.17%
HV 30-Day
87.42%
HV 60-Day
71.10%
HV Rank
98.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($55.39 target)
5
Strong Buy9
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026